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†Department of Molecular and Cellular Biology and ‡Department of Physics, University of Arizona, Tucson, ArizonaABSTRACT To elucidate pathogen-host interactions during early Lyme disease, we developed a mathematical model that
explains the spatiotemporal dynamics of the characteristic first sign of the disease, a large (R5-cm diameter) rash, known as
an erythema migrans. The model predicts that the bacterial replication and dissemination rates are the primary factors
controlling the speed that the rash spreads, whereas the rate that active macrophages are cleared from the dermis is the
principle determinant of rash morphology. In addition, the model supports the clinical observations that antibiotic treatment
quickly clears spirochetes from the dermis and that the rash appearance is not indicative of the efficacy of the treatment.
The quantitative agreement between our results and clinical data suggest that this model could be used to develop more efficient
drug treatments and may form a basis for modeling pathogen-host interactions in other emerging infectious diseases.INTRODUCTIONA goal of modern biomedical research is to develop patient-
specific treatment plans. A potential step in this direction
would be determining effective, noninvasive measures that
correlate clinical observations with states of disease. In
the case of infections, the ability to achieve this goal re-
quires a clear link between the microscopic pathogen-host
interactions and the macroscopic, observable host response.
Quantitative modeling of pathogen-host dynamics can
potentially bridge the gap between these seemingly dispa-
rate length scales. Here we explore this hypothesis in the
context of Lyme disease, the most prevalent vector-borne
illness in the United States and the sixth most notifiable
disease in the nation, which, if untreated, can lead to com-
plications in the heart, joints, or nervous system (1,2).
Specifically, we consider how pathogen-host interactions
lead to the spatial and temporal evolution of erythema
migrans (EM), the characteristic rash that is typically the
first indicator of the disease.
Lyme disease is transmitted to humans by a bite from
Ixodes scapularis ticks infected with the bacterium
Borrelia burgdorferi. In the tick, the spirochetes inhabit
the midgut. During feeding, the bacteria replicate and a
small fraction leave the midgut and migrate to the salivary
glands, where they are then transported into the dermis of
the host via the saliva (3). It takes at least 48 h for the
spirochetes to move from the gut into the dermis (2,3),
and the tick remains attached to the host for ~4–5 days
(2,3). Therefore, at the end of the bloodmeal, a small inoc-
ulum of spirochetes is introduced into the dermis at the
bite site. In the dermis, the spirochetes replicate and begin
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0006-3495/14/02/0763/6 $2.00migration through the dermis can be fairly rapid (at speeds
of a few microns per second (4)), the spirochetes also
bind to extracellular matrix (ECM) proteins and can
become transiently adhered to the matrix (4,5). The tick
bite along with the presence of the spirochetes in the
dermis activates the innate immune response, which
includes uptake of spirochetes by immune effector cells
(2,6,7). Consequently, dendritic cells release cytokines
that act as a signal to monocytes from the bloodstream
to differentiate into phagocytic cells, such as macrophages
(8,9). The release of proinflammatory cytokines by macro-
phages leads to further recruitment of innate immune cells
and T cells to the infected region (2,7). This inflammatory
cascade also causes hyperemia in the capillaries, leading to
the characteristic rash that is usually the first symptom of
infection (2,3).
The EM rash, then, serves as a marker for the innate
immune response during the initial stages of Lyme disease
and should be sensitive to the pathogen-host dynamics
that accompany this disease. But what features of the spiro-
chetal infection and immune response are the most impor-
tant factors of the spread of this rash? Clearly, because
most infections do not produce similar rashes, the behavior
of the bacterium must be important. Here we hypothesize
that the motility of the bacterium is a prime factor and
that the details of the immune response are less important.
To test this hypothesis, we developed a mathematical model
that contains many of the basic features of the dynamics of
each of these processes (Fig. 1 and Materials and Methods).
We show that this minimalistic model is sufficient to explain
the clinically observed progression of the early stages of
Lyme disease and predicts which pathogen-host interactions
are most relevant in determining the morphology and
spreading rate of the EM rash. These results suggest that
this simple yet quantitative model can be informative about
the efficacy of antibiotics. Simulations then predicted thehttp://dx.doi.org/10.1016/j.bpj.2013.12.017
764 Vig and Wolgemuthrate that spirochetes are cleared from the dermis under
typical treatment.MATERIALS AND METHODS
The mathematical model
Our model for pathogen-host dynamics captures the spread of the Lyme
disease rash using parameters that have direct physical interpretations.
The model contains spirochetes that grow with a replication rate, r: As
the spirochetes disseminate through the collagen-rich extracellular matrix,
transient adhesions to the matrix result in the formation of two spirochete
populations, a translocating population, which we denote as T, and a sta-
tionary population (4), S. The switch between these two states is defined
by first-order reactions with transition rate constants kon for binding to
the matrix (T/S) and koff for unbinding from the matrix (S/T). When
stationary spirochetes release from the matrix and become translocating
spirochetes, they often change direction. Therefore, on long timescales,
the spirochetes exhibit diffusive behavior. The diffusion coefficient is
then related to the average velocity of the translocators divided by the off
rate, D ¼ n2/koff, where n is the velocity of the spirochetes.
The host’s innate immune system responds to these invading pathogens
via a complex signaling pathway that involves recognition of the pathogen
and activation and inhibition of immune cells by pro- and antiinflammatory
cytokine release (10,11). Here we simplify this system by lumping many of
these affects together into a local immune response. Proinflammatory cyto-
kines activate monocytes from the blood, which differentiate into macro-
phage cells (8). These activated macrophages are significantly more
effective at clearing spirochetes than the monocytes and are the first phago-
cytes to arrive at the site of spirochete inoculation (12). We denote the
dermal density of active macrophages asM, and use this population to track
the immune response. We assume that the pool of monocytes in the blood is
fairly constant and that macrophage activation is proportional to the local
spirochete burden. We, therefore, use a first-order reaction to describe the
activation of the macrophages with an activation rate constant a. This
assumption is consistent with in vitro data that cytokine release increases
monotonically with the concentration of spirochetes (13). While these
assumptions are an oversimplification, it can serve as a test for how impor-
tant the details of the immune response are to the spread of the EM rash.
Macrophages migrate toward invading spirochetes. Movement of the
macrophages is modeled using the Keller-Segel model for chemotaxis
(14), which sets the speed that the macrophages migrate toward a popula-
tion of bacteria as being proportional to the gradient of the bacterial concen-
tration. A chemotactic rate constant, c, defines the speed. Using that
macrophages can move at a rate of microns per minute allows us to estimate
c. Active macrophages phagocytose the spirochetes. Experiments suggest
that the rate of phagocytosis is dependent on the ratio of macrophages to
spirochetes (15). We, therefore, model phagocytosis as a second-order reac-
tion that depends on both the macrophage and spirochete concentrations
with a clearing rate constant c. Finally, macrophages are cleared from the
dermis with a clearing rate constant, d.
Other groups (see Segel et al. (16) and Penner et al. (17)) have derived
complex reaction-diffusion equations to describe the innate immune
signaling that leads to the formation of a skin rash. Our model is based
on a highly reduced version of this previous work. Therefore, we propose
the following model for the pathogen-host interactions that occur during
the early stages of Lyme disease:
vT
vt
¼ DV2T|ﬄﬄ{zﬄﬄ}
Dissemination through host
þ rT|{z}
Replication rate
þ koffS|ﬄ{zﬄ}
Dermal release
 konT|ﬄ{zﬄ}
Dermal binding
 cMT|ﬄ{zﬄ}
Clearing rate
; (1)Biophysical Journal 106(3) 763–768vSvt
¼ rSþ koffT  konS cMS; (2)
vM .

.
vt
¼ V $ cMV ðT þ SÞ|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
Chemotaxis toward bacteria
þ aðT þ SÞ|ﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄ}
Activation rate
 dM|{z}
Clearing rate
:
(3)
We assume circular symmetry about the bite site and that the dermis is thin
compared to the lateral extent of the rash. Therefore, we simulated the
dynamics of Eqs. 1–3 in axially symmetric, polar coordinates using a
discrete finite volume method with a semiimplicit Crank-Nicholson
time-stepping routine. The equations were solved in MATLAB (The
MathWorks, Natick, MA) using a 40-cm grid of 300 nodes and a time-
step of 102 days, with runs simulated for a total time of 20–30 days.RESULTS AND DISCUSSION
To construct our model for the evolution of the EM rash, we
first consider the spirochete-specific dynamic processes that
occur in the host (Fig. 1 A). The bacteria translocate through
the dermis with velocity n, which is estimated to be ~1–
4 mm/s based on intravital imaging and in vitro measure-
ments in gelatin matrices (4). Spirochetes also bind to the
ECM using adhesion molecules expressed on the outer
membrane with rate constant kon. These stuck or stationary
bacteria unbind with rate constant koff and translocate away
from this location, often in a new direction. The rate con-
stants are likely of ~0.01 s1 (4). Because the bacteria
swim in roughly straight paths and can randomly change
direction, dissemination through the dermis is modeled as
a diffusive process, with diffusion coefficient D ~ n2/koff.
The bacteria also replicate at a rate r (~1–2 days1) (18).
Next, we consider the pathogen-host interactions
(Fig. 1 B). Identification of the invading spirochetes triggers
cytokine release that causes monocytes from the blood to
become activated macrophages. We lump this entire activa-
tion pathway into a single, first-order process with a rate
constant a (~1 days1) (8). The macrophages track the bac-
teria using chemotaxis; their speed is proportional to the
gradient of the bacterial concentration. A rate constant c
(~5 days1) defines the rate that bacteria are cleared from
the dermis by the macrophages. The macrophages are
cleared or die at a rate d (~0.2 days1) (19), which is likely
comparable to the timescale associated with the antiinflam-
matory response. Parameters values are given in Table S1 in
the Supporting Material.
Clinical observations of erythema migrans in patients
with Lyme disease are classified into three separate mor-
phologies: homogenous erythemas, which are solid, fairly
uniform colored rashes (Fig. 2 a); central clearing rashes,
which are rashes whose cleared center is surrounded by a
single ring (Fig. 2 b); and central erythemas, which are
the characteristic bull’s-eye rashes that can have single or
multiple rings (Fig. 2 c). We used our model to simulate
FIGURE 1 Schematic of the model. (A) The
pathogen-specific dynamic processes that occur
in the host. Our model includes translocation of
the spirochetes through the dermis with velocity
n, binding and unbinding of the spirochetes to the
ECM with rate constants kon and koff, respectively,
and replication at a rate r. (B) The pathogen-host
interactions. We consider macrophage activation
from a pool of monocytes, which is proportional
to the concentration of bacteria and a rate constant
a. The macrophages then use chemotaxis to pursue
the bacteria, which are cleared by the macrophages
with a rate constant c. The macrophages are
cleared or die at a rate d. Parameter values are
given in the text and Table S1 in the Supporting
Material. To see this figure in color, go online.
Dynamics of the Lyme Disease Rash 765the spatiotemporal dynamics of spirochetes and activated
macrophages in the dermis. Because inflammation causes
the rash, we use the density of macrophages as an indicator
of the rash appearance. Simulations of this model then
reproduce all three rash morphologies (Fig. 2, d–f) and pre-
dict that the principle contributor to the formation of theHom
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rash morphology are the macrophage clearing rate, spirochete replication rate, an
Movie S5, and Movie S6 in the Supporting Material. To see this figure in colordifferent Lyme disease rashes is the rate at which active
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766 Vig and Wolgemuthbacterial replication rate and the incubation period for the
infection were also found to affect the morphology of
the Lyme disease rash (Fig. 2, j and k).
One benefit of the model is that it allows us to predict
the densities of the bacteria in relationship to the rash as
a function of time during spreading. Fig. 2 g shows a radial
slice through a simulated central erythema and shows how
the spirochete and macrophage populations change as the
rash progresses. The model predicts that the rash begins
as a small homogeneous rash. Activation of the innate
immune response is strongest at the center of the rash
and clears most, but not all, of the bacteria from the center
within ~1 week. However, bacteria at the edge of the rash
continue to spread outward, further activating the immune
response away from the edge. Therefore, the rash grows,
but the center becomes less inflamed. As time progresses,
though, the spirochetes resurge at the center, leading to the
characteristic bull’s-eye pattern often observed with Lyme
disease (Fig. 2 g). This local resurgence near the site of
the initial inoculation has been observed in experiments
on mice where spirochete burden was measured in the
dermis of an infected foot over the course of 55 days
(20). Our simulations and these experiments both show
an initial resurgence within approximately one week after
infection.
A clinical trial with 24 Lyme disease patients measured
the diameter of the Lyme disease rash after an incubation
period (21). Fitting the clinical data with our model, we
concluded that a diffusion coefficient %1 cm2/day was
necessary to recreate the clinically observed spreading ve-
locity range of 1–3 cm/day (3,21,22) (Fig. 2 h). This approx-
imate value for the diffusion coefficient is exactly what is
predicted based on the speed that the bacteria move through
the dermis and the rate that they unbind from the ECM (4)
(Fig. 1). An alternative mechanism driving the spread of the
EM rash could be that cytokine reactions and diffusion are
sufficient to account for the spatiotemporal dynamics.
However, if spreading were controlled by cytokine diffu-
sion, then any localized skin infection could lead to a large
rash. In addition, measurements of cytokine mobility
through epidermal mimics suggest that cytokine diffusion
coefficients are ~10-fold smaller than the coefficient that
we estimate for B. burgdorferi (23). Therefore, it is unlikely
that the EM rash is solely determined by cytokine dynamics.
Our model lets us further examine what pathogen-host
interactions determine the rate at which the rash spreads.
We find that the two most dominant parameters are the bac-
terial diffusion and replication rates. Indeed, we find that the
spreading velocity is linearly dependent on the square-root
of the product of these two parameters (Fig. 2 i). In addition,
we find that macrophage chemotaxis toward the bacteria
does not affect the rash appearance or the overall clearing
of the bacteria. Instead, monocytes in the immediate vicinity
must be activated into macrophages to clear the spirochetes
from a given region. These findings suggest then that theBiophysical Journal 106(3) 763–768rate of rash spreading is determined by pathogen-specific
parameters. The model then suggests that strains of Borrelia
found in Europe and Asia, which cause larger skin lesions,
may replicate or disseminate faster than the strains that
produce more slowly spreading rashes.
For B. burgdorferi to evade the immune response, it
seems counterproductive that the spirochetes bind to the
ECM. It was recently suggested, though, that this stationary
population of bacteria could be beneficial, with the sta-
tionary state acting as a decoy that allows the translocating
bacteria to escape (4). We used our model to explore this
hypothesis and found that the stationary state does not assist
immune evasion. However, the presence of the stationary
state only leads to minor increases in the number of bacteria
that get cleared and similarly small reductions in the
spreading rate (see Fig. S1 in the Supporting Material).
Therefore, binding to the ECM is not strongly detrimental
to infection and likely provides some other benefit to the
bacterium.
The standard treatment plan for a patient presenting with
Lyme disease is doxycycline or amoxicillin administered for
no more than 30 days (24). The dosage of these treatments is
set to maintain the antibiotic concentration in the blood
above the minimum inhibitory concentration over this
time period. Although this treatment plan is usually success-
ful in clearing the bacterial infection, our model provides a
means for predicting the efficacy of different modes of
antibiotic therapies on clearing spirochetes from the dermis.
We therefore modeled antibiotic treatment by assuming that
a patient presenting with a given rash morphology was
administered antibiotic such that the effective antibiotic
concentration in the dermis was maintained at the minimum
inhibitory concentration. We then simulated the progression
of each rash type over the course of four weeks of treatment.
For all three rash morphologies, we found that bacteria were
cleared from the dermis within roughly the first week of
treatment; however, the dynamics of disappearance of the
rash appearance varied depending on the type of EM with
which the patient presented (Fig. 3).
Rashes characterized by central erythema or central
clearing rashes resolved within the first week of antibiotic
treatment, whereas homogenous erythemas were still pre-
sent, in some cases, even after four weeks. The model
suggests that the homogeneous EM will persist longer
than the other rash types, because the appearance of this
type of rash is predicted to depend most strongly on the
clearing rate of the macrophages, which is slower for homo-
geneous erythemas. Therefore, the inflammation is pre-
dicted to persist longer in patients with homogeneous
rashes. Clinical findings support some of these predictions.
For example, studies done in the United States and Europe
have found that 10-day antibiotic regimes are as effective
as longer-term treatments and that the persistence of the
EM rash beyond the treatment time-frame is not necessarily
an indicator of the efficacy of the therapy (25,26).
FIGURE 3 Effects of antibiotic therapy on the clearing of the three rash types. (a–c) Homogeneous rashes are predicted to take longer to clear than
central clearing and central erythemas. (d–f) Normalized total number of bacteria (blue) and macrophages (red) as a function of time. For all rashes,
the bacteria are mostly cleared within a few days; however, for homogeneous rashes, the macrophages take longer to clear due to the slower clearing
rate. Parameter values for the rashes are the same as in Fig. 2. See Movie S7, Movie S8, and Movie S9 in the Supporting Material. To see this figure in color,
go online.
Dynamics of the Lyme Disease Rash 767Here we have described a simple model for the pathogen-
host interactions that occur during the first weeks of Lyme
disease. This model captures the spreading rate and morpho-
logical characteristics of EM rashes, which suggests that
the series of fundamental processes that we consider, i.e.,
replication and migration of the spirochetes, activation and
subsequent chemotaxis of phagocytic cells (such as macro-
phages) that then track down and kill the bacteria, and,
finally, deactivation or death of the macrophages, are the
dominant features affecting the spread of the infection
through the host. Each of these processes is characterized
by a single parameter, which can, in principle, be experi-
mentally measured and/or clinically perturbed. Other
models have also investigated skin rash dynamics but
have focused primarily on describing the complex sig-
naling that is involved in the innate immune response
(10,11,16,17,27,28).
Our results suggest that, at least in the context of the
Lyme disease rash, the details of the immune response are
not as important as the fundamental processes that we
considered. However, we expect that a full description of
the innate immune response will produce quantitative differ-
ences to what we predict here and would provide a better
description of the spreading of the rash. Therefore, our
model can stand as a basis for subsequent work in this field.
In addition, the quantitative agreement among the model,
experimental data, and clinical findings suggest the possi-
bility for developing mathematically guided treatment
paradigms for this disease and possibly other emerginginfectious diseases, similar to what has been done with
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